Literature DB >> 24321215

Toxoplasma gondii impairs memory in infected seniors.

Patrick D Gajewski1, Michael Falkenstein2, Jan G Hengstler2, Klaus Golka2.   

Abstract

Almost 30% of humans present a Toxoplasma gondii positive antibody status and its prevalence increases with age. The central nervous system is the main target. However, little is known about the influence of asymptomatic i.e. latent Toxoplasmosis on cognitive functions in humans. To investigate neurocognitive dysfunctions in asymptomatic older adults with T. gondii positive antibody status a double-blinded neuropsychological study was conducted. The participants were classified from a population-based sample (N=131) of healthy participants with an age of 65 years and older into two groups with 42 individuals each: Toxoplasmosis positive (T-pos; IgG>50 IU/ml) and Toxoplasmosis negative (T-neg; IgG=0 IU/ml). The outcome measures were a computer-based working-memory test (2-back) and several standardized psychometric tests of memory and executive cognitive functions. T-pos seniors showed an impairment of different aspects of memory. The rate of correctly detected target symbols in a 2-back task was decreased by nearly 9% (P=0.020), corresponding to a performance reduction of about 35% in working memory relative to the T-neg group. Moreover, T-pos seniors had a lower performance in a verbal memory test, both regarding immediate recall (10% reduction; P=0.022), delayed recognition (6%; P=0.037) and recall from long-term memory assessed by the word fluency tests (12%; P=0.029). In contrast, executive functions were not affected. The effects remained mostly unchanged after controlling for medication. The impairment of memory functions in T-pos seniors was accompanied by a decreased self-reported quality of life. Because of the high prevalence of asymptomatic Toxoplasmosis and an increasing population of older adults this finding is of high relevance for public health.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Cognition; Dopamine; Memory; Toxoplasma gondii

Mesh:

Year:  2013        PMID: 24321215     DOI: 10.1016/j.bbi.2013.11.019

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  28 in total

1.  Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort.

Authors:  Vishwajit L Nimgaonkar; Robert H Yolken; Tianxiu Wang; Chung-Chou H Chang; Lora McClain; Eric McDade; Beth E Snitz; Mary Ganguli
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

Review 2.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

3.  Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

Authors:  Ajay R Bharti; Allen McCutchan; Reena Deutsch; Davey M Smith; Ronald J Ellis; Mariana Cherner; Steven P Woods; Robert K Heaton; Igor Grant; Scott L Letendre
Journal:  Clin Infect Dis       Date:  2016-10-28       Impact factor: 9.079

4.  Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection.

Authors:  L Ene; T D Marcotte; A Umlauf; C Grancea; A Temereanca; A Bharti; C L Achim; S Letendre; S M Ruta
Journal:  J Neuroimmunol       Date:  2016-08-04       Impact factor: 3.478

5.  Association between Toxoplasma gondii seropositivity and memory function in nondemented older adults.

Authors:  Cynthia P Wyman; Shawn D Gale; Ariana Hedges-Muncy; Lance D Erickson; Eric Wilson; Dawson W Hedges
Journal:  Neurobiol Aging       Date:  2017-02-03       Impact factor: 4.673

6.  Inhibition of Toxoplasma gondii Growth by Dihydroquinine and Its Mechanisms of Action.

Authors:  Aarin M Huffman; Joseph A Ayariga; Audrey Napier; Boakai K Robertson; Daniel A Abugri
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

7.  Delayed IL-12 production by macrophages during Toxoplasma gondii infection is regulated by miR-187.

Authors:  Heng Jiang; Tao Zhai; Yanhui Yu; Xin Li; Pengtao Gong; Xichen Zhang; Guojiang Li; Jianhua Li
Journal:  Parasitol Res       Date:  2020-02-17       Impact factor: 2.289

8.  Hepatitis C virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample.

Authors:  Ibtihal Ibrahim; Hala Salah; Hanan El Sayed; Hader Mansour; Ahmed Eissa; Joel Wood; Warda Fathi; Salwa Tobar; Ruben C Gur; Raquel E Gur; Faith Dickerson; Robert H Yolken; Wafaa El Bahaey; Vishwajit Nimgaonkar
Journal:  J Clin Exp Neuropsychol       Date:  2016-06-07       Impact factor: 2.475

9.  The association of Toxoplasma gondii IgG and cognitive function scores: NHANES 2013-2014.

Authors:  R Constance Wiener; Christopher Waters; Ruchi Bhandari
Journal:  Parasitol Int       Date:  2020-05-13       Impact factor: 2.230

10.  Prevalence of Toxoplasma gondii infection in brain and heart by Immunohistochemistry in a hospital-based autopsy series in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Luis Francisco Sánchez-Anguiano; Alejandra Mendoza-Larios; Jesús Hernández-Tinoco; José Francisco Pérez-Ochoa; Elizabeth Irasema Antuna-Salcido; Elizabeth Rábago-Sánchez; Oliver Liesenfeld
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.